Statements (32)
Predicate | Object |
---|---|
gptkbp:instanceOf |
benzodiazepine
sedative |
gptkbp:administered_via |
oral
|
gptkbp:ATCCode |
N05CA06
|
gptkbp:CASNumber |
76-27-5
|
gptkbp:chemical_compound |
C10H12N2O3
|
gptkbp:discoveredBy |
1930s
|
gptkbp:excretion |
gptkb:kidney
|
gptkbp:hasInChIKey |
QJQYQZPXZQYEME-UHFFFAOYSA-N
|
gptkbp:hasSMILES |
O=C1NC(=O)NC(=O)C1(CC2=CCCCC2)CC
|
gptkbp:hasUNII |
6K3WJA5Z1T
|
https://www.w3.org/2000/01/rdf-schema#label |
cyclobarbital
|
gptkbp:IUPACName |
5-cyclohex-2-en-1-yl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione
|
gptkbp:legalStatus |
prescription only (varies by country)
|
gptkbp:marketedAs |
Dormisan
Phanodorm |
gptkbp:meltingPoint |
110°C
|
gptkbp:metabolism |
liver
|
gptkbp:molecularWeight |
208.22 g/mol
|
gptkbp:PubChem_CID |
6137
5910 |
gptkbp:relatedTo |
phenobarbital
barbital |
gptkbp:sideEffect |
drowsiness
respiratory depression dependence |
gptkbp:synonym |
cyclobarbitol
cyclobarbitone |
gptkbp:usedFor |
sedative
hypnotic |
gptkbp:bfsParent |
gptkb:Bamital
|
gptkbp:bfsLayer |
7
|